ReviewMolecular biology reports2026
Oleuropein in disease prevention and treatment: A comprehensive review from mechanisms to applications.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The olive family, Oleaceae, is a diverse and widely distributed group of flowering plants that encompasses a rich variety of species with significant ecological, economic, and cultural importance. Oleuropein (OLE) is the most abundant polyphenolic compound in olive leaf extract that exhibits a broad spectrum of pharmacological activities, including antioxidant, anti-inflammatory, anti-tumor, anti-apoptotic, and anti-autophagic effects. These properties render it a promising compound for a wide range of applications. This review summarizes recent research on the potential applications of OLE in disease treatment, with particular emphasis on its underlying mechanisms, including antioxidant activity, regulation of endogenous redox-related enzymes, modulation of key inflammatory signaling pathways, and suppression of pro-inflammatory cytokine production. In addition, this review discusses the latest clinical trials involving OLE and its potential as an adjunct treatment.
Indexed as
Identifiers
42319593What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.